$Histogenics(HSGX)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-11-10 AccNo: 0001193125-16-765874 Size: 3 MB 网页链接
$Histogenics(HSGX)$ 8-K - Current report Filed: 2016-11-10 AccNo: 0001193125-16-765172 Size: 86 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Histogenics(HSGX)$ EFFECT - Notice of Effectiveness Filed: 2016-11-04 AccNo: 9999999995-16-006154 Size: 1 KB 网页链接
$Histogenics(HSGX)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2016-11-04 AccNo: 0001193125-16-760309 Size: 231 KB 网页链接
$Histogenics(HSGX)$ DEF 14A - Other definitive proxy statements Filed: 2016-11-02 AccNo: 0001193125-16-756229 Size: 256 KB 网页链接
$Histogenics(HSGX)$ 美东时间 2016-11-10 09:00 Before Open:HISTOGENICS CP Earning Release . Wall St EPS Est ($):-0.62. 网页链接
$Histogenics(HSGX)$ PRER14A - Preliminary Proxy Soliciting materials Filed: 2016-10-27 AccNo: 0001193125-16-748749 Size: 258 KB 网页链接
$Histogenics(HSGX)$ 8-K - Current report Filed: 2016-10-24 AccNo: 0001193125-16-744571 Size: 33 KBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Histogenics(HSGX)$ D - Notice of Exempt Offering of Securities Filed: 2016-10-12 AccNo: 0001671400-16-000002 Size: 13 KB 网页链接
$Histogenics(HSGX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-10-06 AccNo: 0001104659-16-149047 Size: 100 KB 网页链接